Edition:
United States

Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

33.59USD
23 Oct 2018
Change (% chg)

$-0.53 (-1.55%)
Prev Close
$34.12
Open
$33.29
Day's High
$33.59
Day's Low
$33.10
Volume
5,626
Avg. Vol
163,823
52-wk High
$54.45
52-wk Low
$12.75

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.00 -1.147
Mar '18 0.00 -1.047
FY 2017 Dec '17 0.00 -1.152
Sep '17 0.00 -1.020
Jun '17 0.00 -0.938
Mar '17 0.00 -0.883
FY 2016 Dec '16 0.00 -0.631
Sep '16 0.00 -0.881
Jun '16 0.00 -0.659
Mar '16 0.00 -0.580
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 0.00 0.00 0.00 0.00
Quarter Ending Mar-19 2 0.00 0.00 0.00 0.32
Year Ending Dec-18 6 0.00 0.00 0.00 4.51
Year Ending Dec-19 6 0.83 2.98 0.00 84.92
Earnings (per share)
Quarter Ending Dec-18 7 -1.15 -0.85 -1.28 -0.81
Quarter Ending Mar-19 3 -1.27 -1.24 -1.33 -0.86
Year Ending Dec-18 7 -4.44 -3.97 -4.70 -4.36
Year Ending Dec-19 7 -4.92 -4.14 -5.98 -3.11
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 119.85 32.14
P/E High - Last 5 Yrs. -- 284.29 46.82
P/E Low - Last 5 Yrs. -- 95.75 24.71
Beta 2.58 0.63 0.87
Price to Sales (TTM) -- 109.82 6.55
Price to Book (MRQ) 3.77 13.72 4.00
Price to Tangible Book (MRQ) 3.77 20.21 6.10
Price to Cash Flow (TTM) -- 69.50 21.51
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.20 1.45
Dividend 5 Year Growth Rate -- 2.61 -5.91
Payout Ratio(TTM) -- 5.68 46.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 157.56 7.91
Sales (TTM) vs TTM 1 Yr. Ago -- 91.25 6.56
Sales - 5 Yr. Growth Rate -- 25.47 7.49
EPS (MRQ) vs Qtr. 1 Yr. Ago -22.26 297.15 26.63
EPS (TTM) vs TTM 1 Yr. Ago -31.00 -- --
EPS - 5 Yr. Growth Rate -- 25.12 7.65
Capital Spending - 5 Yr. Growth Rate -- 39.11 8.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.22
Current Ratio (MRQ) 15.61 5.52 2.99
LT Debt to Equity (MRQ) 0.00 15.33 11.31
Total Debt to Equity (MRQ) 0.00 18.80 14.15
Interest Coverage (TTM) -- -216.32 34.46

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 32.64 54.36
Gross Margin - 5 Yr. Avg. -- 52.76 53.16
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -164.07 16.13
Operating Margin (TTM) -- -618.88 3.36
Operating Margin - 5 Yr. Avg. -- -178.92 11.28
Pre-Tax Margin (TTM) -- -615.68 3.79
Pre-Tax Margin - 5 Yr. Avg. -- -181.48 11.54
Net Profit Margin (TTM) -- -604.79 0.60
Net Profit Margin - 5 Yr. Avg. -- -179.91 7.83
Effective Tax Rate (TTM) -- 11.98 20.73
Effective Tax Rate - 5 Yr. Avg. -- 19.65 24.38

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,741,437 725,680,242
Net Income/Employee (TTM) -858,027 1,102,410 84,001,075
Receivable Turnover (TTM) -- 4.18 5.06
Inventory Turnover (TTM) -- 2.14 3.65
Asset Turnover (TTM) 0.00 0.39 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -43.08 0.35 9.83
Return on Assets - 5 Yr. Avg. -34.10 3.11 10.94
Return on Investment (TTM) -45.47 1.96 12.83
Return on Investment - 5 Yr. Avg. -35.69 2.91 14.05
Return on Equity (TTM) -47.13 1.12 14.95
Return on Equity - 5 Yr. Avg. -39.11 -0.97 15.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -45.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Atara Biotherapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.31 -5.55 99 59
13 Week -7.29 -10.51 99 76
26 Week 4.56 -5.28 99 56
52 Week 132.35 105.35 99 83
YTD 107.96 92.76 99 84
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 190
Total Shares Held: 49,330,624
3 Mo. Net Change: -7,227
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 9
# Reduced Positions: 7
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.